Skip to main content
. 2017 Dec 6;103(2):546–554. doi: 10.1210/jc.2017-01958

Table 1.

Physical, Hormonal, and Metabolic Characteristics of Pair-Matched (for Age and Race) Obese Adolescent Girls With PCOS vs Without PCOS

Variables PCOS (n = 21) Non-PCOS (n = 21) P Value
Physical characteristics
 Age, y 13.6 ± 2.2 (0.5) 13.3 ± 2.2 (0.5)
 Race (AA/AW), n (%) 9 (43)/12 (57) 9 (43)/12 (57)
 Tanner stage (III/IV/V), n (%) 5 (24)/5 (24)/11 (52) 2 (10)/3 (14)/16 (76) 0.258
 BMI, kg/m2 32.7 ± 4.5 (1.0) 33.3 ± 5.4 (1.2) 0.593
 Total fat mass, kg 36.5 ± 9.3 (2.1) 37.1 ± 10.3 (2.3) 0.770
 Percent body fat, % 43.2 ± 4.8 (1.1) 45.0 ± 5.3 (1.2) 0.225
 Visceral adipose tissue, cm2 69.2 ± 29.2 (6.7) 49.2 ± 22.1 (5.1) 0.011
Sex steroid profile
 Total testosterone, ng/dL 35.9 ± 17.0 (4.2) 24.7 ± 11.4 (2.9) 0.042
 SHBG, nmol/L 17.5 ± 9.7 (2.5) 31.3 ± 19.1 (4.9) 0.026
 Free testosterone, pg/mL 9.8 ± 7.1 (1.9) 4.4 ± 2.8 (0.7) 0.003
 Estradiol, pg/mL 63.8 ± 56.9 (13.4) 76.2 ± 57.5 (13.5) 0.530
 DHEAS, μg/dL 186.8 ± 126.8 (27.7) 118.1 ± 81.4 (17.8) 0.007
Lipid profile
 Total cholesterol, mg/dL 161.5 ± 38.5 (8.4) 154.0 ± 24.6 (5.4) 0.439
 TG, mg/dL 132.5 ± 67.2 (14.7) 89.5 ± 32.7 (7.1) 0.008
 HDL, mg/dL 42.2 ± 10.8 (2.4) 42.8 ± 6.5 (2.4) 0.840
 TG/HDL ratio 3.6 ± 2.6 (0.6) 2.2 ± 1.0 (0.2) 0.023
 LDL, mg/dL 92.8 ± 35.4 (7.7) 93.6 ± 24.2 (5.3) 0.924
 VLDL, mg/dL 25.5 ± 13.4 (3.1) 16.9 ± 5.4 (1.2) 0.013
Metabolic characteristics
 Hemoglobin A1c 5.4 ± 0.4 (0.1) 5.2 ± 0.4 (0.1) 0.183
 Fasting glucose, mg/dL 95.1 ± 7.3 (1.6) 96.9 ± 6.0 (1.3) 0.478
 Fasting insulin, µU/mL 53.8 ± 35.6 (7.8) 36.3 ± 17.1 (3.7) 0.065
 Fasting FFA, mmol/L 0.35 ± 0.12 (0.03) 0.33 ± 0.13 (0.03) 0.730
 Fasting HGP, mg/kg/min 2.4 ± 0.8 (0.2) 2.3 ± 0.5 (0.1) 0.716
 Peripheral IS, (mg/kg/min per µU/mL) × 100 1.8 ± 1.0 (0.2) 2.5 ± 1.2 (0.3) 0.032
 Adiponectin, µg/mL 6.1 ± 3.1 (0.8) 9.9 ± 4.4 (1.1) 0.015

Values are mean ± standard deviation (standard error of the mean) or n (%), unless otherwise indicated.

Abbreviations: AA, African American; AW, American white; HDL, high-density lipoprotein; HGP, hepatic glucose production; LDL, low-density lipoprotein; VLDL, very low-density lipoprotein.

HHS Vulnerability Disclosure